References
- Cox DJ, Gonder-Frederick LA, Kovatchev BP, et al. Progressive hypoglycemia’s impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care 2000;23:163-70
- Graveling AJ, Warren RE, Frier BM. Hypoglycaemia and driving in people with insulin-treated diabetes: adherence to recommendations for avoidance. Diabetic Med 2004;21:1014-19
- Clarke WL, Cox DJ, Gonder-Frederick LA, Kovatchev B. Hypoglycemia and the decision to drive a motor vehicle by persons with diabetes. JAMA 1999;282:750-4
- Driver and Vehicle Licensing Agency. 2014. Available at: https://www.gov.uk/current-medical-guidelines-dvla-guidance-for-professionals-conditions-d-to-f#diabetes—managed-by-tablets-which-carry-a-risk-of-inducing-hypoglycaemia-this-includes-sulphonylureas-and-glinides [Last accessed October 2014]
- Type 2 diabetes in adults: management. NICE guidelines [NG28] Published date: December 2015. https://www.nice.org.uk/guidance/ng28
- UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7
- Brod M, Wolden M, Christensen T, Bushnell DM. A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes Obes Metab 2013;15:546-57
- Evans M, Khunti K, Mamdani M, et al. Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries. Health Qual Life Outcomes 2013;11:90
- Frier BM. Impaired hypoglycaemia awareness. In: Hypoglycaemia in Clinical Diabetes, 2nd edn. Chichester: John Wiley & Sons, 2007:141-70
- Weigner K, Kinsley BT, Levy CJ, et al. The perception of safe driving ability during hypoglycemia in patients with type 1 diabetes mellitus. Am J Med 1999;107:246-53
- Stork AD, Van Haeften TW, Veneman TF. The decision not to drive during hypoglycemia in patients with type 1 and type 2 diabetes according to hypoglycemia awareness. Diabetes Care 2007;30:2822-6
- Alvarez Guisasola F, Tofé Povedano S, Krishnarajah G, et al. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab 2008;10(Suppl 1):25-32
- Schloot NC, Haupt A, Schütt M, et al.; German/Austrian DPV Initiative. Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: how big is the problem? Which patients are at risk? Diabetes Metab Res Rev 2015: published online 26 September 2015, doi: 10.1002/dmrr.2722
- Health and Care Social Information Center. Prescribing for Diabetes. England 2005–06 to 2013–14. Available at: http://www.hscic.gov.uk/catalogue/PUB14681/pres-diab-eng-200506-201314-rep.pdf
- Strain WD, Cos X, Hirst M, et al. Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract 2014;105:302-12
- Parkes A, Tong S, Fernandez-Medina K. The forgotten risk of driving with hypoglycaemia in type 2 diabetes. Published project report 720. Available at: http://www.trl.co.uk/umbraco/custom/report_files/PPR720.pdf [Last accessed 24 January 2016]
- Pedersen-Bjergaard U, Færch L, Allingbjerg ML, et al. The influence of new European Union driver’s license legislation on reporting of severe hypoglycemia by patients with type 1 diabetes. Diabetes Care 2015;38:29-33
- Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991;8:217-22
- Pedersen-Bjergaard U, Pramming S, Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 2003;19:232-40
- Harris SB, Khunti K, Landin-Olsson M, et al. Descriptions of health states associated with increasing severity and frequency of hypoglycemia: a patient-level perspective. Patient Prefer Adherence 2013;7:925-36
- Evans M, Jensen HH, Bøgelund M, et al. Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey. J Med Econ 2013;16:1357-65
- Östenson CG, Geelhoed-Duijvestijn P, Lahtela J, et al. Self-reported non-severe hypoglycaemic events in Europe. Diabet Med 2014;31:92-101